These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27575657)

  • 21. Quality by design approach for formulation development: a case study of dispersible tablets.
    Charoo NA; Shamsher AA; Zidan AS; Rahman Z
    Int J Pharm; 2012 Feb; 423(2):167-78. PubMed ID: 22209997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An integrated Quality by Design (QbD) approach towards design space definition of a blending unit operation by Discrete Element Method (DEM) simulation.
    Adam S; Suzzi D; Radeke C; Khinast JG
    Eur J Pharm Sci; 2011 Jan; 42(1-2):106-15. PubMed ID: 21056102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceptance Probability (P a) Analysis for Process Validation Lifecycle Stages.
    Alsmeyer D; Pazhayattil A; Chen S; Munaretto F; Hye M; Sanghvi P
    AAPS PharmSciTech; 2016 Apr; 17(2):516-22. PubMed ID: 26024723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Process characterization and Design Space definition.
    Hakemeyer C; McKnight N; St John R; Meier S; Trexler-Schmidt M; Kelley B; Zettl F; Puskeiler R; Kleinjans A; Lim F; Wurth C
    Biologicals; 2016 Sep; 44(5):306-18. PubMed ID: 27464992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
    Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategy for design NIR calibration sets based on process spectrum and model space: An innovative approach for process analytical technology.
    Cárdenas V; Cordobés M; Blanco M; Alcalà M
    J Pharm Biomed Anal; 2015 Oct; 114():28-33. PubMed ID: 26001330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An engineering study on the enhanced control and operation of continuous manufacturing of pharmaceutical tablets via roller compaction.
    Singh R; Ierapetritou M; Ramachandran R
    Int J Pharm; 2012 Nov; 438(1-2):307-26. PubMed ID: 22982489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using an innovative combination of quality-by-design and green analytical chemistry approaches for the development of a stability indicating UHPLC method in pharmaceutical products.
    Boussès C; Ferey L; Vedrines E; Gaudin K
    J Pharm Biomed Anal; 2015 Nov; 115():114-22. PubMed ID: 26183807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of experiments (DoE) in pharmaceutical development.
    N Politis S; Colombo P; Colombo G; M Rekkas D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):889-901. PubMed ID: 28166428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody.
    Awotwe-Otoo D; Agarabi C; Wu GK; Casey E; Read E; Lute S; Brorson KA; Khan MA; Shah RB
    Int J Pharm; 2012 Nov; 438(1-2):167-75. PubMed ID: 22944306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid exploration of curing process design space for production of controlled-release pellets.
    Kristan K; Horvat M
    J Pharm Sci; 2012 Oct; 101(10):3924-35. PubMed ID: 22833184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-time product attribute control to manufacture antibodies with defined N-linked glycan levels.
    Zupke C; Brady LJ; Slade PG; Clark P; Caspary RG; Livingston B; Taylor L; Bigham K; Morris AE; Bailey RW
    Biotechnol Prog; 2015; 31(5):1433-41. PubMed ID: 26179435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrated process analytical technology (PAT) approach to monitoring the effect of supercooling on lyophilization product and process parameters of model monoclonal antibody formulations.
    Awotwe Otoo D; Agarabi C; Khan MA
    J Pharm Sci; 2014 Jul; 103(7):2042-2052. PubMed ID: 24840395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel approach to establishing the design space for the oral formulation manufacturing process.
    Norioka T; Hayashi Y; Onuki Y; Andou H; Tsunashima D; Yamashita K; Takayama K
    Chem Pharm Bull (Tokyo); 2013; 61(1):39-49. PubMed ID: 23302585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Identification of Critical Quality Attributes (CQAs) for the Development of Antibody Drugs].
    Saitoh S
    Yakugaku Zasshi; 2018; 138(12):1475-1481. PubMed ID: 30504661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematical approach of formulation and process development using roller compaction.
    Teng Y; Qiu Z; Wen H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of rapidly dissolving pellets within the Quality by Design approach.
    Karatzas AA; Politis SN; Rekkas DM
    Drug Dev Ind Pharm; 2017 May; 43(5):770-779. PubMed ID: 27625003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy.
    Cao M; De Mel N; Shannon A; Prophet M; Wang C; Xu W; Niu B; Kim J; Albarghouthi M; Liu D; Meinke E; Lin S; Wang X; Wang J
    MAbs; 2019 Apr; 11(3):489-499. PubMed ID: 30786796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality by design approach of a pharmaceutical gel manufacturing process, part 1: determination of the design space.
    Rosas JG; Blanco M; González JM; Alcalá M
    J Pharm Sci; 2011 Oct; 100(10):4432-41. PubMed ID: 21567406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns.
    del Val IJ; Kontoravdi C; Nagy JM
    Biotechnol Prog; 2010; 26(6):1505-27. PubMed ID: 20665659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.